401 related articles for article (PubMed ID: 17088580)
1. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
Ceglia L; Lau J; Pittas AG
Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis.
Pittas AG; Westcott GP; Balk EM
Lancet Diabetes Endocrinol; 2015 Nov; 3(11):886-94. PubMed ID: 26341170
[TBL] [Abstract][Full Text] [Related]
3. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT
Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721
[TBL] [Abstract][Full Text] [Related]
4. Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
Garg SK; Mathieu C; Rais N; Gao H; Tobian JA; Gates JR; Ferguson JA; Webb DM; Berclaz PY
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S5-S16. PubMed ID: 19772449
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; Deakin M; Philip S
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003890. PubMed ID: 19160227
[TBL] [Abstract][Full Text] [Related]
6. Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
Cochrane Database Syst Rev; 2004; (3):CD003890. PubMed ID: 15266506
[TBL] [Abstract][Full Text] [Related]
7. Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
Cochrane Database Syst Rev; 2003; (3):CD003890. PubMed ID: 12917994
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
Quattrin T; Bélanger A; Bohannon NJ; Schwartz SL;
Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
[TBL] [Abstract][Full Text] [Related]
9. Summaries for patients. Inhaled insulin with or instead of oral medications for type 2 diabetes.
Ann Intern Med; 2005 Oct; 143(8):I28. PubMed ID: 16230717
[No Abstract] [Full Text] [Related]
10. Inhaled human insulin.
Strack TR
Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
12. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.
Rosenstock J; Cappelleri JC; Bolinder B; Gerber RA
Diabetes Care; 2004 Jun; 27(6):1318-23. PubMed ID: 15161782
[TBL] [Abstract][Full Text] [Related]
13. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.
Rosenstock J; Lorber DL; Gnudi L; Howard CP; Bilheimer DW; Chang PC; Petrucci RE; Boss AH; Richardson PC
Lancet; 2010 Jun; 375(9733):2244-53. PubMed ID: 20609970
[TBL] [Abstract][Full Text] [Related]
14. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.
Cappelleri JC; Cefalu WT; Rosenstock J; Kourides IA; Gerber RA
Clin Ther; 2002 Apr; 24(4):552-64. PubMed ID: 12017400
[TBL] [Abstract][Full Text] [Related]
15. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
[TBL] [Abstract][Full Text] [Related]
16. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
Skyler JS; Weinstock RS; Raskin P; Yale JF; Barrett E; Gerich JE; Gerstein HC;
Diabetes Care; 2005 Jul; 28(7):1630-5. PubMed ID: 15983312
[TBL] [Abstract][Full Text] [Related]
17. Insulin glargine: a systematic review of a long-acting insulin analogue.
Wang F; Carabino JM; Vergara CM
Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.
Ang E; Lawrence MK; Heilmann CR; Ferguson JA; Tobian JA; Webb DM; Berclaz PY
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S35-44. PubMed ID: 19772447
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis.
Akbari V; Hendijani F; Feizi A; Varshosaz J; Fakhari Z; Morshedi S; Mostafavi SA
J Endocrinol Invest; 2016 Feb; 39(2):215-25. PubMed ID: 26105973
[TBL] [Abstract][Full Text] [Related]
20. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
Mathieu C
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
